ABSTRACT
Long segments of disease continue to provide a technical challenge to the interventionist on a regular basis. The most frequently vexing questions in these cases can be summed up as follows:
• Which balloon length to choose? • How much of a long area of disease should
be stented? • Should we be aiming for ‘spot-stenting’ of
only the tightest disease? • How much should we worry about side
branches that are crossed by the stent? • Which branches are worth ‘protection’? • Is there an ideal stent in these circumstances? • What is the experience of the monorail
Wallstent® in native vessels? • Are there data available to suggest that abcix-
imab is indicated solely on the grounds of ‘long stented’ segments?
